{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:51:31Z","timestamp":1791139891994,"version":"4.1.0"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Research and Development Foundation"},{"name":"Franciscus Research Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Data on variation in outcomes and costs of the treatment of inflammatory bowel disease (IBD) can be used to identify areas for cost and quality improvement. It can also help healthcare providers learn from each other and strive for equity in care. We aimed to assess the variation in outcomes and costs of IBD care between hospitals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a 12-month cohort study in 8 hospitals in the Netherlands. Patients with IBD who were treated with biologics and new small molecules were included. The percentage of variation in outcomes (following the International Consortium for Health Outcomes Measurement standard set) and costs attributable to the treating hospital were analyzed with intraclass correlation coefficients (ICCs) from case mix\u2013adjusted (generalized) linear mixed models.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 1010 patients (median age 45 years, 55% female). Clinicians reported high remission rates (83%), while patient-reported rates were lower (40%). During the 12-month follow-up, 5.2% of patients used prednisolone for more than 3 months. Hospital costs (outpatient, inpatient, and medication costs) were substantial (median: \u20ac8323 per 6 months), mainly attributed to advanced therapies (\u20ac6611). Most of the variation in outcomes and costs among patients could not be attributed to the treating hospitals, with ICCs typically between 0% and 2%. Instead, patient-level characteristics, often with ICCs above 50%, accounted for these variations.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Variation in outcomes and costs cannot be used to differentiate between hospitals for quality of care. Future quality improvement initiatives should look at differences in structure and process measures of care and implement patient-level interventions to improve quality of IBD care.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial Registration Number<\/jats:title>\n                  <jats:p>NL8276<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae095","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T11:57:47Z","timestamp":1714132667000},"page":"332-343","source":"Crossref","is-referenced-by-count":5,"title":["Variation Between Hospitals in Outcomes and Costs of IBD Care: Results From the IBD Value Study"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3052-596X","authenticated-orcid":false,"given":"Reinier C A","family":"van Linschoten","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland , Rotterdam ,","place":["the Netherlands"]},{"name":"Department of Gastroenterology and Hepatology, Erasmus MC , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Janneke","family":"van der Woude","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Erasmus MC , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyke","family":"Visser","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland , Rotterdam ,","place":["the Netherlands"]},{"name":"Department of Gastroenterology and Hepatology, Erasmus MC , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"van Leeuwen","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Centre , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G L","family":"Bodelier","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Amphia Hospital , Breda ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fitzpatrick","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, IJsselland Hospital , Capelle aan de IJssel ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"de Jonge","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Albert Schweitzer Hospital , Dordrecht ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hestia","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Ikazia Hospital , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Evelyne","family":"Verweij","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Maasstad Hospital , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanne","family":"van der Wiel","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Reinier de Graaf Gasthuis , Delft ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan","family":"Nieboer","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Centre , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Birnie","sequence":"additional","affiliation":[{"name":"Department of Statistics and Education, Franciscus Gasthuis and Vlietland , Rotterdam ,","place":["the Netherlands"]},{"name":"Department of Genetics, University Medical Centre Groningen, University of Groningen , Groningen ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00eblle","family":"van der Horst","sequence":"additional","affiliation":[{"name":"Crohn & Colitis NL , Woerden ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A","family":"Hazelzet","sequence":"additional","affiliation":[{"name":"Department of Public Health, Erasmus University Medical Centre , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"van Noord","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"West","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Franciscus Gasthuis and Vlietland , Rotterdam ,","place":["the Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"4","key":"2025021012302963400_CIT0001","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1093\/ibd\/izx100","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part I","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025021012302963400_CIT0002","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/ibd\/izy015","article-title":"Quality of life in inflammatory bowel disease: a systematic review and meta-analyses-part II","volume":"24","author":"Knowles","year":"2018","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025021012302963400_CIT0003","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/apt.16445","article-title":"Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents","volume":"54","author":"van Linschoten","year":"2021","journal-title":"Aliment Pharmacol Ther."},{"issue":"3","key":"2025021012302963400_CIT0004","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/apt.14430","article-title":"Market share and costs of biologic therapies for inflammatory bowel disease in the USA","volume":"47","author":"Yu","year":"2018","journal-title":"Aliment Pharmacol Ther."},{"issue":"10114","key":"2025021012302963400_CIT0005","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"2025021012302963400_CIT0006","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41575-020-00360-x","article-title":"The four epidemiological stages in the global evolution of inflammatory bowel disease","volume":"18","author":"Kaplan","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"issue":"5","key":"2025021012302963400_CIT0007","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S2468-1253(23)00003-1","article-title":"The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission","volume":"8","author":"Burisch","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"2025021012302963400_CIT0008","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1093\/ecco-jcc\/jjac099","article-title":"Patient-reported outcomes: the ICHOM Standard Set for Inflammatory Bowel Disease in real-life practice helps quantify deficits in current care","volume":"16","author":"Wong","year":"2022","journal-title":"J Crohns Colitis."},{"issue":"5","key":"2025021012302963400_CIT0009","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1093\/ecco-jcc\/jjv036","article-title":"Value-based health care for inflammatory bowel diseases","volume":"9","author":"van Deen","year":"2015","journal-title":"J Crohns Colitis."},{"issue":"6","key":"2025021012302963400_CIT0010","doi-asserted-by":"publisher","first-page":"CD000259","DOI":"10.1002\/14651858.CD000259.pub3","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev."},{"issue":"3","key":"2025021012302963400_CIT0011","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000528070","article-title":"Significant differences in IBD care and education across Europe: results of the pan-European VIPER survey","volume":"41","author":"Kral","year":"2022","journal-title":"Dig Dis."},{"issue":"7","key":"2025021012302963400_CIT0012","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1111\/j.1365-2036.2007.03445.x","article-title":"Differences in the management of Crohn\u2019s disease among experts and community providers, based on a national survey of sample case vignettes","volume":"26","author":"Esrailian","year":"2007","journal-title":"Aliment Pharmacol Ther."},{"issue":"2","key":"2025021012302963400_CIT0013","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.cgh.2008.08.029","article-title":"Controversies in ulcerative colitis: a survey comparing decision making of experts versus community gastroenterologists","volume":"7","author":"Spiegel","year":"2009","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"6","key":"2025021012302963400_CIT0014","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/j.cgh.2014.11.020","article-title":"Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States","volume":"13","author":"Ananthakrishnan","year":"2015","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2025021012302963400_CIT0015","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/gastro\/gox005","article-title":"Variations in the medical treatment of inflammatory bowel disease among gastroenterologists","volume":"6","author":"Singh","year":"2018","journal-title":"Gastroenterology Report"},{"issue":"12","key":"2025021012302963400_CIT0016","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1080\/14712598.2018.1537367","article-title":"Wide variation in the use and understanding of therapeutic drug monitoring for anti-TNF agents in inflammatory bowel disease: an inexact science","volume":"18","author":"Samaan","year":"2018","journal-title":"Expert Opin Biol Ther."},{"issue":"11","key":"2025021012302963400_CIT0017","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1097\/MIB.0000000000000933","article-title":"Variation in care of Inflammatory Bowel Diseases Patients in Crohn\u2019s and Colitis Foundation of America Partners: role of gastroenterologist practice setting in disease outcomes and quality process Measures","volume":"22","author":"Weaver","year":"2016","journal-title":"Inflamm Bowel Dis."},{"issue":"3","key":"2025021012302963400_CIT0018","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/ibd\/izy276","article-title":"Quality of care in patients With Inflammatory Bowel Disease","volume":"25","author":"Jackson","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"26","key":"2025021012302963400_CIT0019","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMp1011024","article-title":"What is value in health care","volume":"363","author":"Porter","year":"2010","journal-title":"N Engl J Med."},{"issue":"1","key":"2025021012302963400_CIT0020","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1186\/s12913-020-05614-7","article-title":"Redefining value: a discourse analysis on value-based health care","volume":"20","author":"Steinmann","year":"2020","journal-title":"BMC Health Serv Res."},{"key":"2025021012302963400_CIT0021","volume-title":"Defining Value in \u201cValue-Based Healthcare\u201d. Report of the Expert Panel on Effective Ways of Investing in Health (EXPH)","author":"Lehtonen","year":"2019"},{"issue":"4","key":"2025021012302963400_CIT0022","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/ecco-jcc\/jjx161","article-title":"Developing a standard set of patient-centred outcomes for inflammatory bowel disease-an international, cross-disciplinary consensus","volume":"12","author":"Kim","year":"2018","journal-title":"J Crohns Colitis."},{"issue":"1","key":"2025021012302963400_CIT0023","doi-asserted-by":"publisher","first-page":"e050539","DOI":"10.1136\/bmjopen-2021-050539","article-title":"Value-based care pathway for inflammatory bowel disease: a protocol for the multicentre longitudinal non-randomised parallel cluster IBD Value study with baseline period","volume":"12","author":"van Linschoten","year":"2022","journal-title":"BMJ Open"},{"key":"2025021012302963400_CIT0024","author":"Centraal Bureau voor Statistiek"},{"issue":"7","key":"2025021012302963400_CIT0025","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1136\/gutjnl-2013-305600","article-title":"Development and validation of a rapid, generic measure of disease control from the patient\u2019s perspective: the IBD-control questionnaire","volume":"63","author":"Bodger","year":"2014","journal-title":"Gut."},{"issue":"2","key":"2025021012302963400_CIT0026","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/00365521.2020.1857430","article-title":"Cross-cultural translation and validation of the IBD-control questionnaire in The Netherlands: a patient-reported outcome measure in inflammatory bowel disease","volume":"56","author":"de Jong","year":"2021","journal-title":"Scand J Gastroenterol."},{"issue":"7","key":"2025021012302963400_CIT0027","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/ajg.2009.197","article-title":"The Manitoba IBD index: evidence for a new and simple indicator of IBD activity","volume":"104","author":"Clara","year":"2009","journal-title":"Am J Gastroenterol."},{"issue":"2","key":"2025021012302963400_CIT0028","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/ecco-jcc\/jjad147","article-title":"Validation of the IBD-Control Questionnaire across different sociodemographic and clinical subgroups: Secondary analysis of a nationwide electronic survey","volume":"18","author":"Gebeyehu","year":"2023","journal-title":"J Crohns Colitis."},{"issue":"7","key":"2025021012302963400_CIT0029","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s11136-009-9496-9","article-title":"Development of physical and mental health summary scores from the patient-reported outcomes measurement information system (PROMIS) global items","volume":"18","author":"Hays","year":"2009","journal-title":"Qual Life Res."},{"issue":"10","key":"2025021012302963400_CIT0030","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res."},{"issue":"4","key":"2025021012302963400_CIT0031","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health."},{"key":"2025021012302963400_CIT0032","doi-asserted-by":"publisher","first-page":"221","DOI":"10.2147\/PROM.S274015","article-title":"Patient Experience Monitor (PEM): the development of new short-form picker experience questionnaires for hospital patients with a wide range of literacy levels","volume":"11","author":"Bastemeijer","year":"2020","journal-title":"Patient Relat Outcome Meas"},{"key":"2025021012302963400_CIT0033","volume-title":"International Standard Classification of Education: ISCED 2011","year":"2012"},{"issue":"2","key":"2025021012302963400_CIT0034","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/art.10993","article-title":"The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research","volume":"49","author":"Sangha","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2025021012302963400_CIT0035","doi-asserted-by":"publisher","first-page":"17562848231202159","DOI":"10.1177\/17562848231202159","article-title":"Validity of the self-administered comorbidity questionnaire in patients with inflammatory bowel disease","volume":"16","author":"van Linschoten","year":"2023","journal-title":"Therap Adv Gastroenterol"},{"issue":"1","key":"2025021012302963400_CIT0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5334\/jors.436","article-title":"CastorEDC API: a python package for managing real world data in castor electronic data capture","volume":"11","author":"van Linschoten","year":"2023","journal-title":"J Open Res Softw"},{"issue":"1","key":"2025021012302963400_CIT0037","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1467-9531.2007.00180.x","article-title":"Regression with Missing Ys: an improved strategy for analyzing multiply imputed data","volume":"37","author":"von Hippel","year":"2007","journal-title":"Sociol Methodol"},{"key":"2025021012302963400_CIT0038","doi-asserted-by":"crossref","DOI":"10.1136\/bmjqs-2023-016387","article-title":"Handling missing values in the analysis of between-hospital differences in ordinal and dichotomous outcomes: a simulation study","author":"Van Linschoten","year":"2023;32(12):742-749","journal-title":"BMJ Qual Saf"},{"issue":"134","key":"2025021012302963400_CIT0039","doi-asserted-by":"publisher","first-page":"20170213","DOI":"10.1098\/rsif.2017.0213","article-title":"The coefficient of determination R(2) and intra-class correlation coefficient from generalized linear mixed-effects models revisited and expanded","volume":"14","author":"Nakagawa","year":"2017","journal-title":"J R Soc Interface."},{"issue":"2","key":"2025021012302963400_CIT0040","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1097\/MLR.0b013e3181bd4dc3","article-title":"Meaningful variation in performance: a systematic literature review","volume":"48","author":"Fung","year":"2010","journal-title":"Med Care."},{"issue":"5","key":"2025021012302963400_CIT0041","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1053\/j.gastro.2021.12.246","article-title":"Time to revisit disease classification in Inflammatory Bowel Disease: is the current classification of Inflammatory Bowel Disease good enough for optimal clinical management","volume":"162","author":"Verstockt","year":"2022","journal-title":"Gastroenterology."},{"issue":"9","key":"2025021012302963400_CIT0042","doi-asserted-by":"publisher","first-page":"e12952","DOI":"10.1371\/journal.pone.0012952","article-title":"Molecular reclassification of Crohn\u2019s disease by cluster analysis of genetic variants","volume":"5","author":"Cleynen","year":"2010","journal-title":"PLoS One."},{"issue":"8","key":"2025021012302963400_CIT0043","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/jnnp.2007.137059","article-title":"Variation between hospitals in patient outcome after stroke is only partly explained by differences in quality of care: results from the Netherlands Stroke Survey","volume":"79","author":"Lingsma","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"2025021012302963400_CIT0044","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/qjmed\/hcp169","article-title":"Comparing and ranking hospitals based on outcome: results from The Netherlands Stroke Survey","volume":"103","author":"Lingsma","year":"2010","journal-title":"QJM."},{"issue":"6","key":"2025021012302963400_CIT0045","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/intqhc\/13.6.475","article-title":"Process versus outcome indicators in the assessment of quality of health care","volume":"13","author":"Mant","year":"2001","journal-title":"Int J Qual Health Care."},{"issue":"12","key":"2025021012302963400_CIT0046","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.14309\/ajg.0000000000001547","article-title":"Quality of care program reduces unplanned health care utilization in patients with Inflammatory Bowel Disease","volume":"116","author":"Melmed","year":"2021","journal-title":"Am J Gastroenterol."},{"issue":"5","key":"2025021012302963400_CIT0047","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): determining therapeutic goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2020","journal-title":"Gastroenterology."},{"issue":"10","key":"2025021012302963400_CIT0048","doi-asserted-by":"publisher","first-page":"e0185500","DOI":"10.1371\/journal.pone.0185500","article-title":"A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease","volume":"12","author":"Pillai","year":"2017","journal-title":"PLoS One."},{"issue":"8","key":"2025021012302963400_CIT0049","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/ecco-jcc\/jjaa023","article-title":"Quality of care standards in inflammatory bowel diseases: a European Crohn\u2019s and Colitis Organisation (ECCO) position paper","volume":"14","author":"Fiorino","year":"2020","journal-title":"J Crohns Colitis."},{"issue":"3","key":"2025021012302963400_CIT0050","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ajg.2017.9","article-title":"Fostering collaboration through creation of an IBD learning health system","volume":"112","author":"Johnson","year":"2017","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2025021012302963400_CIT0051","doi-asserted-by":"publisher","first-page":"e1030","DOI":"10.1542\/peds.2011-1700","article-title":"Improved outcomes in a quality improvement collaborative for Pediatric Inflammatory Bowel Disease","volume":"129","author":"Crandall","year":"2012","journal-title":"Pediatrics."},{"issue":"3","key":"2025021012302963400_CIT0052","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/MPG.0000000000003182","article-title":"Reduced systemic corticosteroid use among pediatric patients with inflammatory bowel disease in a large learning health system","volume":"73","author":"Kandavel","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr."},{"issue":"1","key":"2025021012302963400_CIT0053","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1186\/s12913-020-05841-y","article-title":"Improving quality of stroke care through benchmarking center performance: why focusing on outcomes is not enough","volume":"20","author":"Amini","year":"2020","journal-title":"BMC Health Serv Res."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae095\/57802677\/izae095.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/332\/57802677\/izae095.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/332\/57802677\/izae095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:38:09Z","timestamp":1739191089000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/2\/332\/7658615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":53,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,4,26]]},"published-print":{"date-parts":[[2025,2,6]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae095","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,4,26]]}}}